SEC Form 4 · accession 0000908662-15-000010
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yat Sun Or
Officer — Chief Scientific Officer
Period of report
Jan 6, 2015
Accepted (ET)
Jan 6, 2015 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 6, 2015 | M | 6,960 | $1.2068 | A | 187,187 | D | |
| Common Stock | Jan 6, 2015 | M | 51,044 | $1.2068 | A | 238,231 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.2068 | Jan 6, 2015 | M | 6,960 | D | — | May 25, 2020 | Common Stock | 6,960 | 0 | D |
| Stock Option (right to buy)F1 | $1.2068 | Jan 6, 2015 | M | 51,044 | D | — | Jun 18, 2020 | Common Stock | 51,044 | 0 | D |
Explanation of responses
- F1100% of the shares subject to this option are fully vested and exercisable.